Surgeons’ Volume-Outcome Relationship for Lobectomies and Wedge Resections for Cancer Using Video-Assisted Thoracoscopic Techniques

<table class="table-group" id="tab8"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left" colspan="2">Indications for surgery</td></tr><tr><td align="left">Malignant</td><td align="center"></td></tr><tr><td align="left"> Primary neoplasm of the lung</td><td align="center">162.x, 209.21*</td></tr><tr><td align="left"> Metastatic site</td><td align="center">197.0</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><sup>*</sup>ICD code 209.21 (malignant carcinoid tumor of the lung) came into existence on October 1, 2008.  Prior to October 1, 2008, this type of lung cancer was coded together with 162.x.<br/></td></tr></table>

Minimally Invasive Surgery

tab8

Table 8

Table 8: Surgeons’ Volume-Outcome Relationship for Lobectomies and Wedge Resections for Cancer Using Video-Assisted Thoracoscopic Techniques 